Clinical Experience of Ceftaroline Fosamil in Gram-Positive Infective Endocarditis: A Multicenter Real-World Observational Study
Antibiotics · 05.05.2026 · 15 (5) · 466
DOI: 10.3390/antibiotics15050466 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antibiotics, online erschienen am 05.05.2026. Verfasst von Daniel Arnés-García und 5 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine Department, Hospital Universitario Virgen de las Nieves, 18014 Granada, Spain. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Ceftaroline fosamil (CFT) is a fifth-generation cephalosporin approved in Spain for skin and soft tissue infections and community-acquired pneumonia. CFT may also be useful against endovascular infections. This real-world study aimed to evaluate its effectiveness and safety in patients with Gram-positive (GP) infective endocarditis (IE).
Methods
This observational, retrospective multicenter study enrolled adults with GP-IE treated with CFT for ≥48 h. Recruitment extended from CFT incorporation in participating hospitals through May 2024. Data were gathered on demographic, clinical, and microbiological variables, adverse effects, overall and IE-related mortality, relapses, and a composite unfavorable outcome.
Results
Seventy-six patients (65.8% male) were enrolled, with a mean age of 68.9 ± 12.8 years and an age-adjusted Charlson index of 4; 55.3% had previous moderate/severe valvular heart disease, 35.5% had atrial fibrillation, 34.2% chronic heart failure, 17.1% chronic kidney disease, and 22.4% septic shock. IE was native valve-related in 53.9%, involving the aortic valve in 38.2% and the mitral in 30.3%. Staphylococcus aureus was isolated in 48.7%, being methicillin-resistant in 40.5% of cases. CFT was salvage therapy in 65.8% and combined with other antibiotics in 94.7%. Valve replacement was indicated in 64.5% but performed in only 67.3% of these. At six months, the adverse effect rate was 9.2%, overall crude mortality 38.2%, infection-related mortality 28.9%, and composite unfavorable outcome 40.1%. In multivariate analysis, mortality-related factors were age-adjusted Charlson index, septic shock, and methicillin-sensitive S. aureus.
Conclusions
CFT showed favorable outcomes and acceptable safety in the real-life treatment of GP-related IE in clinically complex patients with high comorbidity and previous antibiotic therapy failures.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Internal Medicine Department, Hospital Universitario Virgen de las Nieves, 18014 Granada, Spain.
- Infectious Diseases Unit, Hospital Puerta de Hierro de Majadahonda, 28222 Madrid, Spain.
- Pharmacy Department, Hospital Puerta de Hierro de Majadahonda, 28222 Madrid, Spain.
- Infectious Diseases and Microbiology Unit, Complejo Hospitalario de Jaén, 23007 Jaén, Spain.
- Pharmacy Department, Hospital Universitario Virgen de las Nieves, Instituto de Investigación Biosanitario de Granada (IBS-Granada), 18014 Granada, Spain.
- Infectious Diseases Unit, Hospital Universitario Virgen de las Nieves, Instituto de Investigación Biosanitario de Granada (IBS-Granada), 18014 Granada, Spain.
ORCID-Profile: Daniel Arnés-García, Svetlana Sadyrbaeva-Dolgova, Carmen Hidalgo-Tenorio
Zitieren
APA
Arnés-García, D., Calderón-Parra, J., Calvo-Salvador, M., Herrero-Rodríguez, C., Sadyrbaeva-Dolgova, S., & Hidalgo-Tenorio, C. (2026). Clinical Experience of Ceftaroline Fosamil in Gram-Positive Infective Endocarditis: A Multicenter Real-World Observational Study. Antibiotics, 15(5), 466. https://doi.org/10.3390/antibiotics15050466
Vancouver
Arnés-García D, Calderón-Parra J, Calvo-Salvador M, Herrero-Rodríguez C, Sadyrbaeva-Dolgova S, Hidalgo-Tenorio C. Clinical Experience of Ceftaroline Fosamil in Gram-Positive Infective Endocarditis: A Multicenter Real-World Observational Study. Antibiotics. 2026;15(5):466. doi:10.3390/antibiotics15050466
BibTeX
@article{ArnsGarca2026,
author = {Arnés-García, Daniel and Calderón-Parra, Jorge and Calvo-Salvador, Marina and Herrero-Rodríguez, Carmen and Sadyrbaeva-Dolgova, Svetlana and Hidalgo-Tenorio, Carmen},
title = {Clinical Experience of Ceftaroline Fosamil in Gram-Positive Infective Endocarditis: A Multicenter Real-World Observational Study},
journal = {Antibiotics},
year = {2026},
volume = {15},
number = {5},
pages = {466},
doi = {10.3390/antibiotics15050466}
}
EUVIMED